SRC transcriptional activation in a subset of human colon cancer cell lines

被引:43
作者
Dehm, S
Senger, MA
Bonham, K [1 ]
机构
[1] Saskatchewan Canc Agcy, Hlth Res Div, Canc Res Unit, Saskatoon, SK S7N 4H4, Canada
[2] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada
[3] Univ Saskatchewan, Div Oncol, Saskatoon, SK S7N 4H4, Canada
基金
英国医学研究理事会;
关键词
c-Src; oncogene activation; transcription; colon cancer;
D O I
10.1016/S0014-5793(00)02354-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human SRC encodes the non-receptor tyrosine kinase pp60(c-Src), which is activated in many human colon cancer cell lines (HCCLs) and tumors. We found that both c-Src protein and mRNA levels were elevated in a subset of HCCLs. Increased c-Src mRNA and protein levels correlated strongly with increased c-Src kinase activity. Nuclear run-on analysis and c-Src mRNA half-life determination demonstrated increased mRNA levels were due to increased transcription of the SRC gene. We also observed decreased c-Src mRNA stability in cell lines that displayed SRC transcriptional activation. Our findings provide the first evidence that SRC transcriptional activation is an important determinant of c-Src expression and activity in HCCLs. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 41 条
[31]   Colorectal cancer: Molecules and populations [J].
Potter, JD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) :916-932
[32]   Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides [J].
Ritchie, S ;
Boyd, FM ;
Wong, J ;
Bonham, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :847-854
[33]  
ROSEN N, 1986, J BIOL CHEM, V261, P3754
[34]  
Staley CA, 1997, CELL GROWTH DIFFER, V8, P269
[35]   INCREASE IN ACTIVITY AND LEVEL OF PP60C-SRC IN PROGRESSIVE STAGES OF HUMAN COLORECTAL-CANCER [J].
TALAMONTI, MS ;
ROH, MS ;
CURLEY, SA ;
GALLICK, GE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :53-60
[36]  
Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO
[37]  
2-N
[38]  
Visser CJT, 1996, LAB INVEST, V74, P2
[39]   DIFFERENTIAL PP60C-SRC ACTIVITY IN WELL AND POORLY DIFFERENTIATED HUMAN COLON CARCINOMAS AND CELL-LINES [J].
WEBER, TK ;
STEELE, G ;
SUMMERHAYES, IC .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :815-821
[40]  
Wiener JR, 1999, CLIN CANCER RES, V5, P2164